Intranasal insulin for Alzheimer's disease
M Hallschmid - CNS drugs, 2021 - Springer
Brain insulin signaling contributes to memory function and might be a viable target in the
prevention and treatment of memory impairments including Alzheimer's disease. This short …
prevention and treatment of memory impairments including Alzheimer's disease. This short …
Frailty as a predictor of cognitive disorders: a systematic review and meta-analysis
MK Borges, M Canevelli, M Cesari… - Frontiers in medicine, 2019 - frontiersin.org
Background/Aim: Current evidence in the literature supports associations between frailty,
cognitive impairment, and dementia. The study aim was to describe the risk of cognitive …
cognitive impairment, and dementia. The study aim was to describe the risk of cognitive …
Intranasal insulin
M Hallschmid - Journal of neuroendocrinology, 2021 - Wiley Online Library
The intranasal (IN) route enables the delivery of insulin to the central nervous system in the
relative absence of systemic uptake and related peripheral side effects. Intranasally …
relative absence of systemic uptake and related peripheral side effects. Intranasally …
Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies
Objective A systematic review and a meta-analysis of both clinical and population-based
studies was undertaken according to the Preferred Reporting Items for Systematic Reviews …
studies was undertaken according to the Preferred Reporting Items for Systematic Reviews …
[HTML][HTML] Vascular cognitive impairment–Past, present, and future challenges
Vascular cognitive impairment (VCI) is a lifelong process encompassing a broad spectrum of
cognitive disorders, ranging from subtle or mild deficits to prodromal and fully developed …
cognitive disorders, ranging from subtle or mild deficits to prodromal and fully developed …
Metabolic syndrome, cognitive impairment and the role of diet: a narrative review
Background: This narrative review presents the association between metabolic syndrome
(MetS), along with its components, and cognition-related disorders, as well as the potential …
(MetS), along with its components, and cognition-related disorders, as well as the potential …
Inflammation and insulin resistance as risk factors and potential therapeutic targets for Alzheimer's disease
A Vinuesa, C Pomilio, A Gregosa… - Frontiers in …, 2021 - frontiersin.org
Overnutrition and modern diets containing high proportions of saturated fat are among the
major factors contributing to a low-grade state of inflammation, hyperglycemia and …
major factors contributing to a low-grade state of inflammation, hyperglycemia and …
Metabolic syndrome and cognitive function
M Tahmi, P Palta, JA Luchsinger - Current Cardiology Reports, 2021 - Springer
Abstract Purpose of Review Metabolic syndrome (MetS) is a cluster of cardiovascular
disease risk factors that are related to several adverse health outcomes, including poor …
disease risk factors that are related to several adverse health outcomes, including poor …
Identifying and evaluating clinical subtypes of Alzheimer's disease in care electronic health records using unsupervised machine learning
N Alexander, DC Alexander, F Barkhof… - BMC Medical Informatics …, 2021 - Springer
Background Alzheimer's disease (AD) is a highly heterogeneous disease with diverse
trajectories and outcomes observed in clinical populations. Understanding this …
trajectories and outcomes observed in clinical populations. Understanding this …
[HTML][HTML] Diabetes mellitus in the young and the old: Effects on cognitive functioning across the life span
E van Duinkerken, CM Ryan - Neurobiology of disease, 2020 - Elsevier
Mild to moderate cognitive decrements are a well-known phenomenon associated with
diabetes mellitus. In this review, we provide an overview of the cognitive consequences of …
diabetes mellitus. In this review, we provide an overview of the cognitive consequences of …